NCT06810505 A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years Status RECRUITING Phase PHASE3
NCT06806293 Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06796998 Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL) Status RECRUITING Phase PHASE2
NCT06794866 A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult Participants Status COMPLETED Phase PHASE3
NCT06783621 A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products Status COMPLETED Phase PHASE4
NCT06774313 A Study to Assess the Adverse Events and How Subcutaneous (SC) Injections and Intravenous (IV) Infusions of ABBV-142 Move Through the Body of Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT06772623 Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations Status RECRUITING Phase PHASE1/PHASE2
NCT06764706 Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis Status RECRUITING Phase N/A
NCT06764693 An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis Status RECRUITING Phase N/A
NCT06742385 Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases Status RECRUITING Phase NA
NCT06742086 A Study to Evaluate the Bioavailability and Food Effects of Oral Venetoclax New Tablet Formulation 2.0 in Healthy Adult Female Participants Status COMPLETED Phase PHASE1
NCT06734351 A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume Status RECRUITING Phase PHASE3
NCT06722430 A Study to Assess Change in How Oral Icalcaprant With Itraconazole Moves Through the Body in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT06722417 A Single Dose Study to Assess Adverse Events and How Oral Icalcaprant Moves Through the Body in Healthy Adult Japanese and Han Chinese Participants Status COMPLETED Phase PHASE1
NCT06718101 A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06712628 A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING Status RECRUITING Phase N/A
NCT06701331 Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06698926 A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult Participants Status COMPLETED Phase PHASE1